- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: panobinostat/LBH589B
Total 163 results
-
Novartis PharmaceuticalsCompletedProstate CancerUnited States
-
Novartis PharmaceuticalsCompletedMultiple MyelomaGermany, Italy, Spain, Canada, United States, Australia
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsTerminatedMyelodysplastic SyndromeUnited States
-
Novartis PharmaceuticalsCompletedHodgkin's LymphomaUnited States, Belgium, Germany, Canada, Singapore, Netherlands, France, Australia, Russian Federation, Israel, Brazil, Italy, New Zealand, Poland
-
University of AarhusMassachusetts General Hospital; Novartis; Aarhus University Hospital; Monash University and other collaboratorsCompleted
-
University of IowaNovartis Pharmaceuticals; Holden Comprehensive Cancer CenterTerminatedMetastatic MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Genentech, Inc.CompletedHead and Neck Cancer | Lung CancerUnited States
-
Novartis PharmaceuticalsTerminatedLeukemia, Myeloid, ChronicUnited States, Germany
-
Novartis PharmaceuticalsCompletedClassical Hodgkin's LymphomaSpain, France, Belgium, Italy, Israel, Germany, United States, Australia, Brazil, Singapore, Malaysia, New Zealand, United Kingdom
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate CancerUnited States
-
Novartis PharmaceuticalsCompletedNeoplasms | Non-Hodgkin LymphomaUnited States, Netherlands
-
Novartis PharmaceuticalsTerminatedChronic Myeloid Leukemia in Chronic PhaseBelgium, Germany
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia (AML)Germany, Spain, United States
-
Anand JillellaNovartis PharmaceuticalsCompletedMantle Cell LymphomaUnited States
-
Novartis PharmaceuticalsTerminatedPrimary Myelofibrosis | Post-Polycythemia Vera | Post-Essential ThrombocytopeniaUnited States
-
Swedish Medical CenterNovartisCompleted
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate Cancer DiseaseUnited States
-
Southern Europe New Drug OrganizationNovartisUnknownAdvanced Solid TumorsSwitzerland
-
John MascarenhasCompleted
-
Novartis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell Lung | MesotheliomaUnited States, Canada
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterTerminatedDiffuse Large B Cell LymphomaUnited States
-
University of Erlangen-Nürnberg Medical SchoolTerminated
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Non-Secretory Plasma Cell Myeloma | PlasmacytosisUnited States
-
Patrick Y. Wen, MDMassachusetts General Hospital; Northwestern University; Novartis; Beth Israel... and other collaboratorsCompleted
-
Deric M Park MDUnknown
-
Roswell Park Cancer InstituteNovartisTerminatedClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
Novartis PharmaceuticalsNo longer availableMultiple MyelomaGermany, Austria, Canada, Jordan, Norway, Sweden
-
Sidney Kimmel Cancer Center at Thomas Jefferson...NovartisTerminatedBrain Metastasis | Recurrent Glioma | High-grade MeningiomaUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer | HER-2 Positive Breast CancerBelgium, Netherlands, Australia, Italy, United States
-
Novartis PharmaceuticalsTerminatedMyelodysplastic Syndrome (MDS)Germany
-
Masonic Cancer Center, University of MinnesotaNovartis Pharmaceuticals; Millennium Pharmaceuticals, Inc.TerminatedPancreatic CancerUnited States
-
Southern Europe New Drug OrganizationNovartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedMultiple MyelomaFrance, Australia, United States, Spain
-
Muhammad FurqanNovartis PharmaceuticalsWithdrawnMelanoma | Non Small Cell Lung Cancer
-
Washington University School of MedicineCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States
-
M.D. Anderson Cancer CenterNovartisCompleted
-
Ohio State University Comprehensive Cancer CenterNovartis; CelgeneCompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin Lymphoma | Adult Nodular Lymphocyte Predominant Hodgkin LymphomaUnited States
-
University of PittsburghNovartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerUnited States
-
Novartis PharmaceuticalsCompletedRelapse/Refractory Multiple MyelomaJapan
-
SCRI Development Innovations, LLCNovartisCompletedBreast CancerUnited States
-
National Cancer Centre, SingaporeNovartisUnknownNasopharyngeal Carcinoma, Lymphomas, Any EBV+ Solid TumourSingapore
-
pharmaand GmbHCompletedMultiple MyelomaCanada, Spain, United States, Czechia, Turkey, France, Sweden, Korea, Republic of, Thailand, Belgium, Greece, Germany, Hungary, Russian Federation, Italy, Poland, Australia, Lebanon, Portugal, Norway, Brazil, Netherlands
-
Novartis PharmaceuticalsWithdrawn
-
NYU Langone HealthNovartisCompletedProstatic Neoplasms | Prostate CancerUnited States
-
Novartis PharmaceuticalsCompletedRefractory Multiple Myeloma | Multiple Myeloma in Relapse | Relapsed and Bortezomib Refractory Multiple MyelomaUnited States
-
SCRI Development Innovations, LLCNovartisTerminated
-
PETHEMA FoundationCompleted
-
Novartis PharmaceuticalsCompletedColorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell CarcinomaUnited States, Spain, Taiwan, Germany, Netherlands, United Kingdom, Korea, Republic of
-
Emory UniversityNovartis; Eisai Inc.TerminatedBreast Cancer | Breast Neoplasms | Breast TumorsUnited States
-
M.D. Anderson Cancer CenterNovartisCompletedHodgkin's LymphomaUnited States